Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Arthritis Rheum. 2006 Mar;54(3):702-10. doi: 10.1002/art.21678.
Arthritis Rheum. 2006.
PMID: 16508926
Free article.
Clinical Trial.